FASN and acute lymphoblastic leukemia: It was revealed that FASN was significantly upregulated in ALL relapsed group compared with the MRD− patients (1.169 ± 0.15 vs. 0.7669 ± 0.09448, mean ± SEM, P = 0.0180).